ICICI Prudential Nifty Healthcare ETF
ICICI Prudential Mutual Fund · Equity ETFs · Regular Growth · AMFI 148957 · ISIN INF109KC1Q72
NAV₹179.378420 Nov 2026
3Y return+20.75%a year
5Y return+15.62%a year
Expense ratio0.18%₹240 Cr
Growth Score—
Returns
| 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 7Y | 10Y | Since launch |
| Fund | +12.33% | +6.11% | +10.49% | +19.80% | +17.86% | +20.75% | +15.62% | — | — | +14.84% |
| NIFTY Healthcare TRI | +12.35% | +6.16% | +10.59% | +20.00% | +18.07% | +20.97% | +15.83% | — | — | — |
| Category middle | +9.44% | +2.23% | +7.03% | +1.53% | +0.66% | +11.16% | +8.98% | +12.69% | +13.37% | — |
Risk (36 months)
| Volatility | 15.64% |
| Sharpe | 0.91 |
| Sortino | 1.48 |
| Beta | 1.00 |
| Alpha | -0.18% |
| Deepest fall | -20.63% |
| 1-year periods with a loss | 23% |
| 5Y SIP XIRR | +19.34% |
Top holdings (31 Oct 2026)
| Sun Pharmaceutical Industries Ltd. | 16.33% |
| Divi's Laboratories Ltd. | 10.78% |
| Laurus Labs Ltd. | 8.12% |
| Apollo Hospitals Enterprise Ltd. | 7.54% |
| Dr. Reddy's Laboratories Ltd. | 7.15% |
| Cipla Ltd. | 6.73% |
| Torrent Pharmaceuticals Ltd. | 5.89% |
| MAX Healthcare Institute Ltd | 5.55% |
| Lupin Ltd. | 4.24% |
| Aurobindo Pharma Ltd. | 4.03% |
| Fortis Healthcare Ltd. | 3.47% |
| Glenmark Pharmaceuticals Ltd. | 3.00% |
Sectors
| Pharmaceuticals & Biotechnology | 81.8% |
| Healthcare Services | 18.2% |
Calculated by Growth Analyser from AMFI NAVs and the fund house's disclosed portfolio. Up to 1 year: total return; longer: CAGR. Research and education only; not investment advice. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance does not indicate future returns.